SymbolIQV
NameIQVIA HOLDINGS INC.
SectorHEALTH CARE
RegionNorth America
IndustryServices-Commercial Physical & Biological Research
Address2400 ELLIS ROAD, DURHAM, NC 27703
Telephone919-998-2000
Fax
Email
Websitehttps://www.iqvia.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001478242
Description

IQVIA Holdings Inc is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Additional info from NASDAQ:
IQVIA Holdings Inc is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

2026-05-13 20:30

IQVIA - IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities

Read more
2026-05-13 20:30

IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities

Read more
2026-05-11 21:07

Director Wims Morris Leslie 🟢 acquired 171 shares (1 derivative) of IQVIA HOLDINGS INC. (IQV) Transaction Date: May 07, 2026 | Filing ID: 033655

Read more
2026-05-11 21:07

Director GOGGINS COLLEEN A 🟢 acquired 214 shares (1 derivative) of IQVIA HOLDINGS INC. (IQV) Transaction Date: May 07, 2026 | Filing ID: 033654

Read more
2026-05-11 21:06

Director Fasano Jim 🟢 acquired 228 shares (1 derivative) of IQVIA HOLDINGS INC. (IQV) Transaction Date: May 07, 2026 | Filing ID: 033653

Read more
2026-05-11 21:05

Director DANHAKL JOHN G 🟢 acquired 185 shares (1 derivative) of IQVIA HOLDINGS INC. (IQV) Transaction Date: May 07, 2026 | Filing ID: 033650

Read more
2026-05-07 21:24

(99% Neutral) IQVIA HOLDINGS INC. (IQV) Files Form 8-K

Read more
2026-05-07 21:15

IQVIA - IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization

Read more
2026-05-07 21:15

IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization

Read more
2026-05-06 20:15

IQVIA - IQVIA CFO to Speak at Bank of America Health Care Conference 2026

Read more